This contribution to the development of molecules that can inhibit bacterial Prx facilitates the selection of natural products, or the synthesis of inhibitors aimed at enhancing specificity and inhibitory activity against Prx, thereby combating infectious and genetic diseases. The gene discussed is PRX; the disease is hereditary disease.